Johnson & Johnson CEDEAR (JNJ)

Profile

https://www.jnj.com

Johnson & Johnson CEDEAR is an Argentine depositary receipt that represents an economic interest in Johnson & Johnson’s ordinary shares, allowing local investors to access the company’s global healthcare exposure in pesos through Argentina’s capital market. Each receipt represents a fractional interest designed to mirror the performance of the underlying U.S. equity, with custody and issuance managed by a local depositary bank. The asset provides exposure to Johnson & Johnson’s diversified operations across Innovative Medicine and MedTech, spanning immunology, oncology, neuroscience, cardiovascular and metabolism, pulmonary hypertension, surgical solutions, orthopedics, and vision care. As a cross-border instrument, it facilitates portfolio diversification and foreign asset access within domestic brokerage accounts, reflecting corporate actions and dividends of the underlying where applicable. Its presence in the local market supports investor participation in one of the world’s largest healthcare companies known for scale, stable cash flows, and an extensive pipeline and device portfolio, while translating pricing, liquidity, and information into the local trading framework for Argentine investors.